Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, Kuchibhotla U, Moyers JS, Benson CT, Gimeno RE, DAlessio DA, Haupt A (2018) LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept
You can usually find this on your BCBS companys website or by logging into your account
Current US clinical trial data and other investigational HDV therapies were also reviewed (see Table 1)
That's when I bought a smart scale
Key documents include your denial letter, sleep study report, OSA diagnosis/severity, BMI documentation, provider notes, and (recommended) a letter of medical necessity from your prescribing provider